NCT06213246

Brief Summary

The primary aim of this study is to assess the changes in strength expression resulting from the performance of a surgical operation among orthopedic surgeons at the IRCCS Galeazzi-Sant'Ambrogio Hospital. To achieve this goal, the assessment of strength expression will be conducted using handgrip measurements before (pre) and after (post) the surgical operation. Additionally, both pre- and post-surgery, there will also be evaluations of changes in actigraphic sleep parameters, salivary cortisol levels, cognitive performance, and subjective perception levels of effort and drowsiness. Te second aim is to assess differences in strength expression, cognitive performance, salivary cortisol levels, perceived effort, and drowsiness levels among surgeons in response to sleep hygiene strategies (week 2 vs week 3).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 22, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 19, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2024

Completed
Last Updated

January 19, 2024

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

December 22, 2023

Last Update Submit

January 9, 2024

Conditions

Keywords

surgerysleepsurgeonstrengthcognitive performance

Outcome Measures

Primary Outcomes (1)

  • Handgrip Test

    Handgrip is a measure of the maximal isometric force that a hand can squeeze, and it is widely used because very easy and inexpensive. The handgrip strength is performed three-times for each hand alternatively, starting with the dominant hand, using a digital dynamometer to the nearest 0.1kg. Participants perform the test in a sitting position with the shoulder adducted, elbow flexed at 90-degree angle, forearm in neutral position. Participants rest 30 seconds among each repetition. The peak of the three repetitions is calculated and use for statistical analysis.

    The handgrip test is conducted on the seventh day of both Week 2 and Week 3, taking approximately 4 minutes to complete. The test is performed both before and after the surgery.

Secondary Outcomes (9)

  • Lower limbs isometric strength

    The maximal isometric strength test of extensors of knee is conducted on the seventh day of both Week 2 and Week 3, taking approximately 5 minutes to complete. The test is performed both before and after the surgery.

  • Sleep monitoring

    Seven days for each timepoint period (week 1, week 2 and week 3. 21 days in total)

  • Stroop Test

    The Stroop test is conducted on the seventh day of both Week 2 and Week 3, taking approximately 2 minutes to complete. The test is performed both before and after the surgery.

  • Bomb Risk Elicitation Task

    The Bomb Risk Elicitation Task is conducted on the seventh day of both Week 2 and Week 3, taking approximately 2 minutes to complete. The test is performed both before and after the surgery.

  • Salivary cortisol

    The assessment of salivary cortisol using "Salivette" is conducted on the seventh day of both Week 2 and Week 3, taking approximately 3 minutes to complete. The assessment is performed both before and after the surgery.

  • +4 more secondary outcomes

Study Arms (1)

Sleep Hygiene Strategies (SHS)

EXPERIMENTAL

In Week 3, the study participants will implement sleep hygiene strategies. Specifically, these sleep hygiene strategies will be applied for all seven days of Week 3 and will involve the guidelines recommended by the National Sleep Foundation.

Behavioral: Sleep Hygiene Strategies

Interventions

The sleep hygiene strategies will be applied for all seven days of Week 3 and will involve the following guidelines recommended by the National Sleep Foundation * Maintain a consistent wake-up and bedtime schedule during workdays. * Do not delay/advance excessively (no more than 2 hours) the wake-up and bedtime - schedule during weekends. * Keep the bedroom temperature below 22°C. * Avoid sources of light and noise in the bedroom. * Use the bed only for sleeping, avoiding other activities before bedtime. * Avoid daytime naps during workdays. * Refrain from using electronic devices (PC, laptop, cellphone, television) at least 30 minutes before bedtime. * Expose yourself to natural light in the morning and reduce artificial lights in the evening. * Avoid consuming alcoholic beverages and caffeine in the afternoon. * Have a moderately sized dinner at least 3 hours before bedtime.

Sleep Hygiene Strategies (SHS)

Eligibility Criteria

Age23 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female, of any ethnicity;
  • Age between 23 and 70 years old;
  • Cognitively intact;
  • Orthopedic surgeons or medical residents specializing in Orthopedics.
  • Signature and acceptance of informed consent to collaborate in all procedures necessary for the study.

You may not qualify if:

  • Individuals younger than 23 years old or older than 70 years old;
  • Any clinical condition that prevents the subject from participating in operating room activities (e.g., muscle injury, COVID-19 positivity, feverish or flu-like states, etc.).
  • Non-participation, for any reason, in surgical activities in daily clinical practice.
  • Clinically diagnosed sleep disorders.
  • Women who have been pregnant or breastfeeding within 12 months before signing the informed consent or during the recruitment and observation period. \[self-declaration\]
  • Non-acceptance of the informed consent.
  • Physical impossibility to undergo the evaluations required by the study using the devices specified in the protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Ospedale Galeazzi-Sant'Ambrogio

Milan, Italy

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: The study is monocentric, prospective, and observational.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2023

First Posted

January 19, 2024

Study Start

October 23, 2023

Primary Completion

December 23, 2024

Study Completion

December 23, 2024

Last Updated

January 19, 2024

Record last verified: 2024-01

Locations